1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Ottiger, M. Zerbe, O. Guntert, P. Wuthrich, K. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 272 64 81 10.1006/jmbi.1997.1220 9299338 The NMR solution conformation of unligated human cyclophilin A. 1997 10.2210/pdb1oca/pdb pdb_00001oca 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 18036.504 CYCLOPHILIN A 5.2.1.8 1 man polymer no no MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD CGQLE MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG EKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIAD CGQLE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample T-CELL (JURKAT) CYCLOPHILIN 9606 Homo sapiens CYCLOPHILIN 562 Escherichia coli W3110CI database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-11-19 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-07-07 REL REL LEAST RESTRAINT VIOLATION 50 20 NOESY HNHB HSQC CBCA (CO)NH CT-HNCA HCCH-TOCSY CT-HCCH-COSY CCH-TOCSY CLEAN-TOCSY HMBC (HB)CB(CGCD)HD HB(CBCGCD)HD TOCSY-RELAYED-CT-HMQC 6.5 299 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. distance geometry WUTHRICH refinement OPAL structure solution DIANA 750 Varian UNITYPLUS 750 600 Bruker AMX600 MET 1 n 1 MET 1 A VAL 2 n 2 VAL 2 A ASN 3 n 3 ASN 3 A PRO 4 n 4 PRO 4 A THR 5 n 5 THR 5 A VAL 6 n 6 VAL 6 A PHE 7 n 7 PHE 7 A PHE 8 n 8 PHE 8 A ASP 9 n 9 ASP 9 A ILE 10 n 10 ILE 10 A ALA 11 n 11 ALA 11 A VAL 12 n 12 VAL 12 A ASP 13 n 13 ASP 13 A GLY 14 n 14 GLY 14 A GLU 15 n 15 GLU 15 A PRO 16 n 16 PRO 16 A LEU 17 n 17 LEU 17 A GLY 18 n 18 GLY 18 A ARG 19 n 19 ARG 19 A VAL 20 n 20 VAL 20 A SER 21 n 21 SER 21 A PHE 22 n 22 PHE 22 A GLU 23 n 23 GLU 23 A LEU 24 n 24 LEU 24 A PHE 25 n 25 PHE 25 A ALA 26 n 26 ALA 26 A ASP 27 n 27 ASP 27 A LYS 28 n 28 LYS 28 A VAL 29 n 29 VAL 29 A PRO 30 n 30 PRO 30 A LYS 31 n 31 LYS 31 A THR 32 n 32 THR 32 A ALA 33 n 33 ALA 33 A GLU 34 n 34 GLU 34 A ASN 35 n 35 ASN 35 A PHE 36 n 36 PHE 36 A ARG 37 n 37 ARG 37 A ALA 38 n 38 ALA 38 A LEU 39 n 39 LEU 39 A SER 40 n 40 SER 40 A THR 41 n 41 THR 41 A GLY 42 n 42 GLY 42 A GLU 43 n 43 GLU 43 A LYS 44 n 44 LYS 44 A GLY 45 n 45 GLY 45 A PHE 46 n 46 PHE 46 A GLY 47 n 47 GLY 47 A TYR 48 n 48 TYR 48 A LYS 49 n 49 LYS 49 A GLY 50 n 50 GLY 50 A SER 51 n 51 SER 51 A CYS 52 n 52 CYS 52 A PHE 53 n 53 PHE 53 A HIS 54 n 54 HIS 54 A ARG 55 n 55 ARG 55 A ILE 56 n 56 ILE 56 A ILE 57 n 57 ILE 57 A PRO 58 n 58 PRO 58 A GLY 59 n 59 GLY 59 A PHE 60 n 60 PHE 60 A MET 61 n 61 MET 61 A CYS 62 n 62 CYS 62 A GLN 63 n 63 GLN 63 A GLY 64 n 64 GLY 64 A GLY 65 n 65 GLY 65 A ASP 66 n 66 ASP 66 A PHE 67 n 67 PHE 67 A THR 68 n 68 THR 68 A ARG 69 n 69 ARG 69 A HIS 70 n 70 HIS 70 A ASN 71 n 71 ASN 71 A GLY 72 n 72 GLY 72 A THR 73 n 73 THR 73 A GLY 74 n 74 GLY 74 A GLY 75 n 75 GLY 75 A LYS 76 n 76 LYS 76 A SER 77 n 77 SER 77 A ILE 78 n 78 ILE 78 A TYR 79 n 79 TYR 79 A GLY 80 n 80 GLY 80 A GLU 81 n 81 GLU 81 A LYS 82 n 82 LYS 82 A PHE 83 n 83 PHE 83 A GLU 84 n 84 GLU 84 A ASP 85 n 85 ASP 85 A GLU 86 n 86 GLU 86 A ASN 87 n 87 ASN 87 A PHE 88 n 88 PHE 88 A ILE 89 n 89 ILE 89 A LEU 90 n 90 LEU 90 A LYS 91 n 91 LYS 91 A HIS 92 n 92 HIS 92 A THR 93 n 93 THR 93 A GLY 94 n 94 GLY 94 A PRO 95 n 95 PRO 95 A GLY 96 n 96 GLY 96 A ILE 97 n 97 ILE 97 A LEU 98 n 98 LEU 98 A SER 99 n 99 SER 99 A MET 100 n 100 MET 100 A ALA 101 n 101 ALA 101 A ASN 102 n 102 ASN 102 A ALA 103 n 103 ALA 103 A GLY 104 n 104 GLY 104 A PRO 105 n 105 PRO 105 A ASN 106 n 106 ASN 106 A THR 107 n 107 THR 107 A ASN 108 n 108 ASN 108 A GLY 109 n 109 GLY 109 A SER 110 n 110 SER 110 A GLN 111 n 111 GLN 111 A PHE 112 n 112 PHE 112 A PHE 113 n 113 PHE 113 A ILE 114 n 114 ILE 114 A CYS 115 n 115 CYS 115 A THR 116 n 116 THR 116 A ALA 117 n 117 ALA 117 A LYS 118 n 118 LYS 118 A THR 119 n 119 THR 119 A GLU 120 n 120 GLU 120 A TRP 121 n 121 TRP 121 A LEU 122 n 122 LEU 122 A ASP 123 n 123 ASP 123 A GLY 124 n 124 GLY 124 A LYS 125 n 125 LYS 125 A HIS 126 n 126 HIS 126 A VAL 127 n 127 VAL 127 A VAL 128 n 128 VAL 128 A PHE 129 n 129 PHE 129 A GLY 130 n 130 GLY 130 A LYS 131 n 131 LYS 131 A VAL 132 n 132 VAL 132 A LYS 133 n 133 LYS 133 A GLU 134 n 134 GLU 134 A GLY 135 n 135 GLY 135 A MET 136 n 136 MET 136 A ASN 137 n 137 ASN 137 A ILE 138 n 138 ILE 138 A VAL 139 n 139 VAL 139 A GLU 140 n 140 GLU 140 A ALA 141 n 141 ALA 141 A MET 142 n 142 MET 142 A GLU 143 n 143 GLU 143 A ARG 144 n 144 ARG 144 A PHE 145 n 145 PHE 145 A GLY 146 n 146 GLY 146 A SER 147 n 147 SER 147 A ARG 148 n 148 ARG 148 A ASN 149 n 149 ASN 149 A GLY 150 n 150 GLY 150 A LYS 151 n 151 LYS 151 A THR 152 n 152 THR 152 A SER 153 n 153 SER 153 A LYS 154 n 154 LYS 154 A LYS 155 n 155 LYS 155 A ILE 156 n 156 ILE 156 A THR 157 n 157 THR 157 A ILE 158 n 158 ILE 158 A ALA 159 n 159 ALA 159 A ASP 160 n 160 ASP 160 A CYS 161 n 161 CYS 161 A GLY 162 n 162 GLY 162 A GLN 163 n 163 GLN 163 A LEU 164 n 164 LEU 164 A GLU 165 n 165 GLU 165 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O THR 157 A O THR 157 A N ALA 11 A N ALA 11 A O VAL 6 A O VAL 6 A N PHE 22 A N PHE 22 A O SER 21 A O SER 21 A N GLU 134 A N GLU 134 A O VAL 127 A O VAL 127 A N MET 100 A N MET 100 A O SER 99 A O SER 99 A N PHE 113 A N PHE 113 A O PHE 112 A O PHE 112 A N GLY 64 A N GLY 64 A O MET 61 A O MET 61 A N ILE 57 A N ILE 57 1 A A HG1 OE2 THR GLU 116 143 1.51 1 A A HG1 OE1 THR GLU 5 23 1.56 1 A A O HG GLY SER 47 51 1.57 2 A A HG1 OE2 THR GLU 116 143 1.52 3 A A HG1 OE2 THR GLU 116 143 1.57 3 A A HG1 OE2 THR GLU 32 86 1.58 4 A A HG1 OE1 THR GLU 116 143 1.54 4 A A HG1 OE1 THR GLU 32 86 1.60 6 A A HG1 OE2 THR GLU 116 143 1.55 6 A A HG1 O THR LYS 152 154 1.55 7 A A HG1 OE2 THR GLU 32 86 1.57 8 A A HG1 OE2 THR GLU 116 143 1.53 8 A A OE1 HH GLU TYR 34 79 1.58 8 A A HG1 OE2 THR GLU 32 86 1.60 10 A A HG1 OE1 THR GLU 5 23 1.51 10 A A HG1 OE2 THR GLU 116 143 1.58 10 A A HG O SER GLU 77 81 1.60 11 A A HG1 OE2 THR GLU 116 143 1.52 11 A A HG1 OE1 THR GLU 32 86 1.59 12 A A OE1 HH GLU TYR 34 79 1.58 12 A A HG1 OE2 THR GLU 116 143 1.58 13 A A HG1 OE2 THR GLU 116 143 1.55 14 A A HG1 OE2 THR GLU 116 143 1.54 15 A A HG1 OE1 THR GLU 116 143 1.52 16 A A HG1 O THR LYS 152 154 1.60 16 A A HG1 OE2 THR GLU 116 143 1.60 17 A A HG1 OE1 THR GLU 5 23 1.56 17 A A HG1 OE2 THR GLU 116 143 1.58 18 A A HG1 OE2 THR GLU 116 143 1.58 18 A A HG O SER GLU 77 81 1.59 18 A A OE2 HH GLU TYR 34 79 1.60 18 A A O HG GLY SER 65 110 1.60 19 A A HG1 OE2 THR GLU 116 143 1.57 20 A A HG1 OE2 THR GLU 116 143 1.53 20 A A HG1 OE2 THR GLU 32 86 1.57 19 A A MET VAL 1 2 -142.97 1 A PHE 36 0.088 SIDE CHAIN 1 A ARG 69 0.086 SIDE CHAIN 1 A ARG 144 0.086 SIDE CHAIN 2 A ARG 37 0.105 SIDE CHAIN 2 A ARG 55 0.105 SIDE CHAIN 3 A ARG 37 0.077 SIDE CHAIN 3 A ARG 55 0.115 SIDE CHAIN 4 A TYR 48 0.094 SIDE CHAIN 5 A ARG 19 0.096 SIDE CHAIN 5 A ARG 55 0.106 SIDE CHAIN 5 A ARG 69 0.102 SIDE CHAIN 5 A PHE 112 0.089 SIDE CHAIN 6 A ARG 55 0.159 SIDE CHAIN 7 A ARG 69 0.082 SIDE CHAIN 8 A TYR 48 0.078 SIDE CHAIN 9 A TYR 48 0.065 SIDE CHAIN 9 A ARG 55 0.094 SIDE CHAIN 10 A ARG 19 0.106 SIDE CHAIN 10 A TYR 48 0.186 SIDE CHAIN 10 A ARG 69 0.082 SIDE CHAIN 11 A TYR 48 0.074 SIDE CHAIN 11 A ARG 144 0.081 SIDE CHAIN 12 A ARG 19 0.085 SIDE CHAIN 12 A TYR 48 0.077 SIDE CHAIN 12 A ARG 69 0.152 SIDE CHAIN 12 A PHE 112 0.095 SIDE CHAIN 13 A TYR 48 0.120 SIDE CHAIN 13 A ARG 55 0.122 SIDE CHAIN 14 A TYR 48 0.075 SIDE CHAIN 16 A TYR 48 0.068 SIDE CHAIN 17 A ARG 55 0.105 SIDE CHAIN 17 A ARG 69 0.095 SIDE CHAIN 19 A ARG 19 0.078 SIDE CHAIN 19 A ARG 69 0.078 SIDE CHAIN 20 A ARG 19 0.080 SIDE CHAIN 20 A PHE 36 0.093 SIDE CHAIN 6 -5.33 0.60 121.00 115.67 A A A CB CG CD2 TYR TYR TYR 48 48 48 N 8 -5.73 0.90 118.30 112.57 A A A CB CG OD2 ASP ASP ASP 13 13 13 N 12 -3.91 0.60 121.00 117.09 A A A CB CG CD2 TYR TYR TYR 48 48 48 N 13 -3.90 0.60 121.00 117.10 A A A CB CG CD2 TYR TYR TYR 48 48 48 N 14 -4.24 0.60 121.00 116.76 A A A CB CG CD2 TYR TYR TYR 48 48 48 N 15 -3.93 0.60 121.00 117.07 A A A CB CG CD2 TYR TYR TYR 48 48 48 N 1 A ASP 13 55.43 13.76 1 A CYS 52 62.94 174.59 1 A PHE 60 -135.84 -79.89 1 A HIS 70 -152.27 34.32 1 A ASN 71 -150.72 12.18 1 A LYS 82 48.38 161.41 1 A ASN 106 39.14 48.17 1 A SER 110 -156.22 -5.59 1 A LYS 118 -64.64 91.96 1 A PHE 129 -140.76 -0.70 1 A SER 147 -146.47 -61.51 1 A ARG 148 141.75 -38.60 2 A PHE 25 -69.61 52.71 2 A PHE 60 -142.03 -62.96 2 A ARG 69 -117.11 -165.90 2 A HIS 70 -174.22 46.83 2 A ASN 71 -166.85 20.82 2 A GLU 81 62.17 -133.63 2 A ALA 101 -95.00 50.92 2 A SER 110 -142.21 -47.13 2 A THR 119 -117.67 72.77 2 A LYS 125 -135.53 -40.31 2 A PHE 129 -145.30 -3.83 3 A VAL 2 48.15 -172.95 3 A ASP 13 56.07 14.03 3 A CYS 52 113.90 161.91 3 A PHE 60 -140.64 -80.36 3 A PHE 67 -58.52 40.10 3 A THR 68 -148.39 -12.96 3 A HIS 70 -169.94 45.21 3 A ASN 71 -155.45 -7.33 3 A THR 73 -91.52 -96.01 3 A GLU 81 -91.58 -139.32 3 A ALA 103 -146.00 36.49 3 A THR 119 -81.03 42.22 4 A ASP 13 53.68 13.37 4 A PHE 60 -137.37 -78.72 4 A THR 68 -125.65 -58.39 4 A ARG 69 -103.94 -158.37 4 A HIS 70 -168.34 41.04 4 A ASN 71 -122.94 -51.59 4 A GLU 81 34.48 -133.82 4 A ASN 102 -76.59 -169.88 4 A ASN 106 34.16 53.02 4 A THR 107 -140.63 23.29 4 A SER 110 -147.06 -39.87 4 A THR 119 -74.10 43.40 4 A SER 147 -137.80 -70.36 4 A ARG 148 143.44 -29.28 5 A ASP 13 50.88 12.94 5 A LYS 49 -59.28 101.71 5 A CYS 52 105.39 161.32 5 A PHE 60 -138.90 -78.29 5 A THR 68 -121.83 -50.72 5 A ARG 69 -106.29 -149.23 5 A HIS 70 -171.19 69.36 5 A ASN 71 -165.60 -77.12 5 A THR 73 -83.60 -73.47 5 A ASP 85 -67.67 89.27 5 A ASN 102 -68.34 -179.25 5 A THR 107 -92.14 39.58 5 A LYS 118 -66.92 96.22 5 A SER 147 -143.63 -103.30 5 A ARG 148 -153.70 -27.03 6 A VAL 2 50.66 -173.40 6 A ASP 13 54.72 14.04 6 A PHE 60 -122.90 -75.98 6 A ASP 66 -84.45 46.21 6 A ARG 69 -125.06 -139.12 6 A HIS 70 -170.06 23.49 6 A GLU 81 33.79 -142.10 6 A ASN 108 -66.29 -154.29 6 A THR 119 -92.98 58.45 7 A ASN 3 -36.34 112.40 7 A PRO 16 -66.95 99.20 7 A PHE 60 -140.67 -81.26 7 A PHE 67 -96.29 35.70 7 A THR 68 -155.00 -67.07 7 A ASN 71 -167.00 4.70 7 A LYS 82 63.40 158.25 7 A ASN 102 -69.26 -179.05 7 A SER 110 -155.74 -21.68 7 A PHE 129 -140.74 -0.22 8 A VAL 2 50.12 -173.11 8 A PHE 25 -81.13 49.54 8 A CYS 52 122.85 167.73 8 A PHE 60 -129.11 -75.57 8 A THR 68 -139.15 -35.41 8 A ASN 71 -164.51 -54.05 8 A LYS 82 52.31 149.88 8 A ASN 102 -165.38 -169.10 8 A ASN 106 34.18 51.04 8 A THR 107 -140.63 13.92 8 A ASN 108 -57.79 96.61 8 A SER 110 -156.29 -17.43 8 A THR 119 -114.21 56.88 8 A LYS 125 -138.91 -45.11 9 A ASP 13 58.71 17.96 9 A PHE 25 -68.97 61.37 9 A CYS 52 86.00 164.93 9 A PHE 60 -146.93 -81.89 9 A PHE 67 -63.34 1.25 9 A THR 68 -139.21 -69.08 9 A HIS 70 -148.25 33.77 9 A ASN 71 -144.96 16.27 9 A LYS 76 170.69 -177.34 9 A GLU 81 -76.24 -133.51 9 A ASN 106 44.93 14.70 9 A SER 110 -144.34 -11.25 9 A CYS 115 -66.68 94.42 9 A LYS 125 -144.25 -34.33 10 A VAL 2 -65.86 -174.26 10 A ASN 3 -27.94 99.98 10 A ASP 13 54.24 13.69 10 A PHE 60 -153.55 -79.23 10 A PHE 67 -33.37 -18.02 10 A HIS 70 -156.17 44.03 10 A ASN 71 -140.34 -8.36 10 A SER 77 -89.63 35.20 10 A ILE 78 42.10 -3.14 10 A GLU 81 -68.50 -132.91 10 A PHE 129 -150.24 1.18 10 A SER 147 -146.14 -81.86 10 A ARG 148 169.06 -21.41 11 A CYS 52 67.11 132.81 11 A PHE 60 -143.13 -81.36 11 A ASN 71 -140.78 10.14 11 A GLU 81 -68.82 -156.22 11 A ASN 87 159.07 157.58 11 A LYS 118 -64.69 84.87 11 A LYS 125 -132.22 -56.97 12 A ASP 13 56.62 13.95 12 A LYS 49 -52.49 108.91 12 A CYS 52 60.18 176.58 12 A PHE 60 -150.32 -76.44 12 A HIS 70 -164.53 54.00 12 A ASN 71 -159.08 -1.29 12 A GLU 81 37.25 -133.50 12 A ASN 106 33.61 54.77 12 A SER 110 -155.92 -30.97 12 A LYS 118 -67.51 89.17 12 A LYS 125 -140.11 -35.00 13 A ASP 13 57.04 13.92 13 A LYS 28 -130.45 -47.89 13 A PHE 60 -142.40 -79.93 13 A HIS 70 -159.80 72.01 13 A ASN 71 -168.79 -10.26 13 A GLU 81 -147.72 -139.26 13 A ALA 101 -97.08 57.12 13 A ASN 106 34.56 47.27 13 A LYS 118 -67.86 89.82 13 A SER 147 -141.62 -86.51 13 A ARG 148 178.14 -17.40 14 A VAL 2 63.89 175.46 14 A ASP 13 57.32 13.94 14 A PHE 60 -150.89 -74.02 14 A PHE 67 -41.16 -2.36 14 A ASN 71 -173.45 -22.94 14 A GLU 81 -135.13 -157.61 14 A ASN 102 -65.98 -178.18 14 A ASN 106 34.21 57.27 14 A SER 110 -151.01 -13.12 14 A LYS 118 -65.52 88.45 15 A VAL 2 48.16 -173.65 15 A ASP 13 58.35 13.82 15 A PHE 25 -69.04 59.11 15 A PHE 60 -133.11 -72.89 15 A THR 68 -140.03 -51.68 15 A ASN 71 -154.07 2.95 15 A SER 77 -71.45 23.16 15 A ILE 78 46.29 -19.13 15 A GLU 81 41.23 -132.80 15 A ALA 101 -102.09 59.22 15 A ALA 103 -147.82 19.84 15 A LYS 118 -67.83 92.10 16 A ASN 3 -44.97 109.19 16 A LYS 44 -67.59 2.49 16 A CYS 52 130.14 144.28 16 A PHE 60 -133.94 -79.61 16 A THR 68 -137.16 -45.95 16 A HIS 70 54.25 12.96 16 A LYS 76 -170.58 -178.84 16 A LYS 82 67.38 148.42 16 A THR 107 -142.25 41.74 16 A SER 147 -142.18 -72.06 16 A ARG 148 140.67 -27.39 17 A VAL 2 46.65 -172.70 17 A PHE 60 -136.57 -75.64 17 A HIS 70 -145.11 53.81 17 A ASN 71 -152.91 -67.37 17 A GLU 81 34.06 -133.80 17 A SER 110 -144.54 -13.76 17 A LYS 118 -68.59 89.85 17 A LYS 125 -127.22 -52.01 17 A SER 147 -142.59 -96.05 17 A ARG 148 -162.20 -23.40 18 A VAL 2 -69.11 -174.26 18 A ASN 3 -33.83 104.79 18 A ASP 13 53.50 13.76 18 A LYS 28 -145.82 -25.25 18 A CYS 52 56.38 175.99 18 A PHE 60 -125.10 -83.89 18 A THR 68 -136.60 -31.57 18 A ASN 71 -147.04 -27.52 18 A SER 77 -84.89 44.93 18 A ILE 78 49.27 -43.59 18 A GLU 81 -127.84 -133.23 18 A ASN 87 167.72 156.42 18 A ALA 101 -77.62 41.79 18 A ASN 106 48.85 24.43 18 A LYS 118 -66.54 93.22 18 A LYS 125 -137.04 -51.91 19 A VAL 2 52.42 179.35 19 A ASP 13 57.44 13.07 19 A CYS 52 47.11 170.29 19 A PHE 60 -134.56 -76.29 19 A THR 68 -139.29 -60.66 19 A ASN 71 -162.46 -0.90 19 A SER 77 -73.74 22.57 19 A ILE 78 49.16 -22.39 19 A GLU 81 50.10 -132.57 19 A ASN 106 37.67 43.91 19 A SER 110 -145.77 33.88 19 A LYS 118 -68.47 96.42 20 A ASN 3 -29.08 98.24 20 A ASP 13 58.68 14.39 20 A LYS 44 -68.06 1.62 20 A CYS 52 106.76 144.64 20 A PHE 60 -143.07 -68.80 20 A THR 68 -122.98 -67.91 20 A HIS 70 60.45 -3.81 20 A GLU 81 -132.44 -137.80 20 A ASN 106 33.62 48.71 20 A SER 110 -146.50 -28.86 20 A THR 119 -74.87 40.67 HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES 1 Y N A PRO 30 A PRO 30 HELX_P A THR 41 A THR 41 1 1 12 A GLU 120 A GLU 120 HELX_P A LEU 122 A LEU 122 5 2 3 A MET 136 A MET 136 HELX_P A PHE 145 A PHE 145 1 3 10 ISOMERASE ISOMERASE, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PPIA_HUMAN UNP 1 1 P62937 VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGE KFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADC GQLE 1 164 1OCA 2 165 P62937 A 1 2 165 8 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ILE 156 A ILE 156 A GLN 163 A GLN 163 A THR 5 A THR 5 A VAL 12 A VAL 12 A GLU 15 A GLU 15 A LEU 24 A LEU 24 A VAL 127 A VAL 127 A GLU 134 A GLU 134 A ILE 97 A ILE 97 A MET 100 A MET 100 A PHE 112 A PHE 112 A CYS 115 A CYS 115 A MET 61 A MET 61 A GLY 64 A GLY 64 A PHE 53 A PHE 53 A ILE 57 A ILE 57 1 P 1